[Infection in the granulocytopenic patient].
Cajozzo
A
A
D000380:Agranulocytosis / Q000150:complications* / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003115:Colony-Stimulating Factors / Q000627:therapeutic use; D004198:Disease Susceptibility; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D017053:Infection Control; D007239:Infections / Q000188:drug therapy / Q000209:etiology*; D009369:Neoplasms / Q000150:complications
D000900:Anti-Bacterial Agents; D003115:Colony-Stimulating Factors; D006133:Growth Substances; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
Infezioni nel paziente granulocitopenico.